Tuesday, August 9, 2022

Omicron: GlaxoSmithKline announces UK-approved drug for new variant

The pharmaceutical company on Thursday said that further tests will be carried out on the Sotrovimab therapy to firm up the results.

• December 2, 2021
GlaxoSmithKline
GlaxoSmithKline

GlaxoSmithKline says a pre-clinical analysis of its antibody-based COVID-19 therapy developed with U.S. partner Vir has yielded positive results against newly identified Omicron variant. 

The pharmaceutical company on Thursday said in a statement that further tests will be carried out on the Sotrovimab therapy to firm up the results.

George Scangos, Chief Executive Officer of Vir, said: “Sotrovimab was deliberately designed with a mutating virus in mind.

“By targeting a highly conserved region of the spike protein that is less likely to mutate, we hoped to address both the current SARS-CoV-2 virus and future variants that we expected would be inevitable.”

This news comes as the UK’s drug regulator approved GSK and Vir Biotechnology’s Xevudy treatment, after findings revealed it to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 infection.

The antibody therapy reduced the risk of hospitalisation and death by 79 per cent in high-risk adults with symptomatic COVID-19 infection during its clinical trials.

Though the UK has already ordered around 100,000 doses of the drug, its Medicines and Healthcare Products Regulatory Agency said it would work with GSK to establish if Omicron will have any impact on its efficacy.

Sotrovimab is authorised for emergency use in the United States and in Japan, and has been approved via the Special Approval for Emergency Pathway. 

The Omicron variant, identified first in South Africa, has been listed as a ‘variant of concern’ and said it could take several weeks to know if there are significant changes in transmissibility, severity or implications for COVID-19 vaccines, tests, and treatments.

The new mutation, which shows resistance to the vaccine and built up immunity, has been identified in multiple countries including Nigeria.

This has led to multiple flight bans and red list placements as governments race to contain the spread of the new variant.

We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.

More from Peoples Gazette

Rangers International Football Club of Enugu

Sport

CHAN Eagles: Rangers FC players invited to camp

Four players of Rangers International FC of Enugu have been called up to the preliminary 35-man list of the CHAN Eagles for qualifiers to the 2023 competition in Algeria.

Showbiz

PMAN should use music to unite divided Nigeria: Runsewe

The NCAC boss urged the association to produce a Nigerian song that will unify all the different ethnic groups in the country.

Enugu

Insecurity: Ugwuanyi tells NSCDC to improve performance in Enugu

“The corps is known for integrity in service delivery and nothing short of that will be given to the good people of the state,” said the NSCDC commandant.

Health

Enugu rated second best in primary healthcare delivery after FCT

ONE Campaign has rated Enugu as the second highest performing state in primary healthcare service delivery in Nigeria from 2019 to 2021.

FRSC at an accident scene

NationWide

FRSC warns motorists to limit speed when driving in rain

The FRSC said the caution became necessary because of the forecast of heavy rainfall.

Heading 5

Disaster worse than Chernobyl, Fukushima likely in Zaporizhzhya nuclear plant, Ukraine warns

Ukraine’s IAEA chief warned of severe consequences not only for Ukraine, but all of Europe.